Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
United Financial Bancorp, Inc. Announces Second Quarter Earnings and Quarterly Dividend

10h globenewswire
HARTFORD, Conn., July 17, 2018 (GLOBE NEWSWIRE) -- United Financial Bancorp, Inc. ("United Financial" or the "Company") (NASDAQ:UBNK), the holding company for United Bank (the "Bank"), announced results for the quarter ended June 30, 2018.
UBNK UDBKL UBLA UBLS

0
MOVES-Exotix Capital hires execs to expand fixed income presence

2018-07-16 reuters
(Reuters) - Exotix Capital, the developing markets investment bank, said it has hired four new executives to expand its global presence in fixed income.
BNPZY UDBKL BNPQY UBLA UBLS BNPQF

0
FinMin seeks more time for PSBs to meet MPS norm

2018-07-16 freepressjournal.in
New Delhi : The finance ministry may approach markets regulator Sebi to seek relaxation on the minimum 25 per cent public shareholding norm for some state banks (PSBs).
INDIANB IOB 500116 UDBKL IDBI UBLS 532418 532814 532505 CNRYY 532388 SYNDIBANK 532276 532121 532483 UBLA UCOBANK CANBK DENABANK ANDHRABANK

0
United Bank of India - Outcome of Board Meeting

2018-07-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UDBKL UBLA UBLS

0
The Trouble With Small-Cap Growth Stocks

2018-07-12 seekingalpha
When we analyze small-cap growth stocks (US and international), we find that the asset class’ relatively poor returns can be explained by the ‘growthiest’ stocks in the category.
UDBKL UBLA UBLS

0
Fed orders United Bank Ltd. to toughen money laundering policies

2018-07-12 reuters
WASHINGTON, July 12 (Reuters) - The Federal Reserve on Thursday ordered United Bank Limited to toughen its anti-money laundering policies as the regulator faulted the Pakistani bank for not doing enough to track suspicious transactions.
UDBKL UBLA UBLS

0
United Bank of India - Shareholders meeting

2018-07-06 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UDBKL UBLA UBLS

0
UK court grants enforcement order in Mallya assets case

2018-07-05 moneycontrol
A UK High Court judge has issued an enforcement order in favour of a consortium of 13 Indian banks, seeking to recover funds owed to them by beleaguered liquor baron Vijay Mallya who is fighting extradition to India on fraud and money laundering charges worth nearly Rs 9,000 crore.
IOB 500116 500469 UDBKL IDBI UBLS FDBAY 532505 FEDA 532388 PNJZY 532461 UBLA FEDS PNB UCOBANK FEDERALBNK SBAZ

0
Vijay Mallya’s London house can be searched, says UK High Court

2018-07-05 livemint
London: A UK High Court judge has issued an enforcement order in favour of a consortium of 13 Indian banks, seeking to recover funds owed to them by beleaguered liquor baron Vijay Mallya who is fighting extradition to India on fraud and money laundering charges worth nearly ₹ 9,000 crore.
IOB 500116 500469 UDBKL IDBI UBLS FDBAY 532505 FEDA 532388 PNJZY 532461 UBLA FEDS PNB UCOBANK FEDERALBNK SBAZ

0
United Bank of India - Interest Rates Updates

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UDBKL UBLA UBLS

1
NewDominion Bank joins Park National organization

2018-07-02 globenewswire
NEWARK, Ohio and CHARLOTTE, N.C., July 02, 2018 (GLOBE NEWSWIRE) -- Park National Corporation (Park) (NYSEAMERICAN:PRK) and NewDominion Bank (NewDominion) (OTCPINK:NDMN) closed a previously announced merger transaction yesterday making NewDominion a community bank division of The Park National Bank. With access to Park National’s resources, NewDominion will broaden its services, including 24/7 client support, larger and more specialized loans and wealth management capabilities.
UDBKL UBLA UBLS PRK

0
United Financial Bancorp, Inc. (UBNK) Announces Dates for Q2 2018 Earnings Release and Conference Call

2018-07-02 globenewswire
HARTFORD, Conn., July 02, 2018 (GLOBE NEWSWIRE) -- United Financial Bancorp, Inc. (“United Financial” or the “Company”) (NASDAQ:UBNK), the holding company for United Bank (the “Bank”), today announced that it expects to release financial results for the second quarter ending June 30, 2018 (Q2 2018) on Tuesday, July 17, 2018, after 4:00 pm Eastern Time (ET). A copy of the earnings release will immediately be made available on the Company’s website at www.
UBNK UDBKL UBLA UBLS

0
United Bank of India - Cessation

2018-07-02 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
UDBKL UBLA UBLS

5
Bank Boards Bureau recommends 15 names for the post of MD in PSU banks

2018-06-30 livemint
Mumbai: The Bank Boards Bureau has recommended the names of 15 officials for the posts of managing director and chief executive officers in several public sector banks.
INDIANB UBNC 500116 UDBKL IDBI ALBK UBLS 532814 CNRYY 532179 SYNDIBANK 532276 532483 CRPKY UBLA 532480 CORPBANK CANBK SBAZ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...